Biotech startup expands at Cummings Center in Beverly

00 Cummings Center

BEVERLY, Mass. – Spectrus has graduated from an incubator lab to 2,400 square feet of space at Cummings Center’s growing biotech cluster in Beverly. The mass spectrometry firm is expected to occupy its new facilities this summer.

Founded in 2017 by Enrique Arevalo and Michael Ziebell, Spectrus provides proteomics services and advanced analytics for biotech and pharmaceutical development organizations.

The life sciences firm is the latest graduate of North Shore InnoVentures, a nonprofit biotech and cleantech incubator located at Cummings Center. The growth of its business from just one to 40 active accounts in the span of a few years prompted the firm to explore independent space options.

“Cummings Center is a great fit for us because it is a short distance from our primary customer base in Cambridge and Boston, its active life science community facilitates connections and hiring, and the lease rates are more affordable than areas closer to the city,” said Ziebell.

Cummings Properties account manager Justin D’Aveta worked with Spectrus CEO Paulo Reátegui on the new office lease. With discussions taking place during the height of Massachusetts’ COVID-19 outbreak, D’Aveta arranged a virtual tour of the suite for the Spectrus team.

“At Cummings Center, we have a front-row seat to the continued development of the North Shore’s thriving biotech community,” said Stephanie Aitchison, associate general manager at Cummings Center. “We are delighted to support Spectrus’ continued growth.”

According to Ziebell, Spectrus aims to steadily increase its full-time workforce each year.

“We are really excited about the room for growth this space affords, said Ziebell. “We think Spectrus has the right balance of scientific knowledge and business sense to grow rapidly in the years ahead, and we look forward to making Cummings our base for this growth and giving back to the community as we do so.”

Spectrus remained operational throughout the recent business closures across the Commonwealth and participated in COVID-19 relief efforts with research in virus detection methods.

Spectrus is a bioanalytical chemistry service provider supporting the biotech and pharmaceutical sectors. It specializes in the characterization of complex molecules by mass spectrometry, and its team provides project consulting, method design, rapid sample processing, and data analysis to clients in the U.S. and worldwide.